Correlia Biosystems, Inc.

Brief Description

Correlia Biosystems develops streamlined assay platforms to reduce the time and cost for quantifying proteins for proteomic and pharmaceutical applications.  Our research instruments provide multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation.  We are dedicated to reducing the cost and time to market for candidate drug compounds, and facilitating the access of researchers to large panel protein studies.


Amy Herr

Tech Category

  • SBIR/STTR Recipient
  • Medical Diagnostics

Join the IPIRA Mailing List




Accessibility | Nondiscrimination | Privacy